• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兰索拉唑与兰索拉唑联合阿莫西林治疗胃溃疡患者幽门螺杆菌根除情况的比较

Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.

作者信息

Sugiyama T, Hisano K, Ochiai T, Fujita N, Kobayashi T, Yabana T, Kurokawa I, Yachi A

机构信息

Department of Laboratory Diagnosis, Sapporo Medical University School of Medicine, Japan.

出版信息

J Clin Gastroenterol. 1995;20 Suppl 2:S104-6. doi: 10.1097/00004836-199506002-00028.

DOI:10.1097/00004836-199506002-00028
PMID:7594322
Abstract

Helicobacter pylori is a major cause of gastritis and an important factor in duodenal ulcer relapse. Eradication of H. pylori has usually been achieved by triple therapy, a combination of bismuth salts and two antibiotics. The disadvantage of these regimens is the large number of tablets and the high incidence of side effects. A new H+,K(+)-ATPase inhibitor, lansoprazole (LPZ), has a strong acid inhibitory effect and an anti-H. pylori effect in vitro. These dual effects have an advantage for the eradication of H. pylori by LPZ alone or by a combination of LPZ and antibiotics. In this study, we investigated an anti-H. pylori effect of LPZ alone and LPZ plus low-dose amoxicillin and the relation between the status of H. pylori colonization and the endoscopic healing stage. LPZ monotherapy suppressed H. pylori but did not eradicate it. LPZ plus low-dose amoxicillin dual therapy eradicated H. pylori in 45.5% of patients with gastric ulcer disease. However, this rate is not satisfactory for eradication therapy. The optimal dosage and duration of treatment need to be specified. A high rate of healing to the endoscopic S2 stage was achieved by eradication of H. pylori and the recurrence of gastric ulcer was suppressed in patients in whom H. pylori was eradicated. The eradication of H. pylori may change the natural course of gastric ulcer disease as it does in duodenal ulcer disease.

摘要

幽门螺杆菌是胃炎的主要病因以及十二指肠溃疡复发的重要因素。根除幽门螺杆菌通常采用三联疗法,即铋盐与两种抗生素联合使用。这些治疗方案的缺点是片剂数量多且副作用发生率高。一种新型的H⁺,K⁺-ATP酶抑制剂兰索拉唑(LPZ)具有很强的抑酸作用,并且在体外具有抗幽门螺杆菌的作用。这些双重作用对于单独使用LPZ或LPZ与抗生素联合使用来根除幽门螺杆菌具有优势。在本研究中,我们调查了单独使用LPZ以及LPZ加小剂量阿莫西林的抗幽门螺杆菌作用,以及幽门螺杆菌定植状态与内镜愈合阶段之间的关系。LPZ单一疗法可抑制幽门螺杆菌,但不能将其根除。LPZ加小剂量阿莫西林的联合疗法使45.5%的胃溃疡病患者根除了幽门螺杆菌。然而,这个根除率对于根除治疗来说并不令人满意。需要确定最佳的治疗剂量和疗程。通过根除幽门螺杆菌可使内镜愈合达到S2期的比例很高,并且根除幽门螺杆菌的患者胃溃疡复发得到了抑制。根除幽门螺杆菌可能会像在十二指肠溃疡病中一样改变胃溃疡病的自然病程。

相似文献

1
Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.兰索拉唑与兰索拉唑联合阿莫西林治疗胃溃疡患者幽门螺杆菌根除情况的比较
J Clin Gastroenterol. 1995;20 Suppl 2:S104-6. doi: 10.1097/00004836-199506002-00028.
2
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.三联疗法与双重疗法根除幽门螺杆菌及预防溃疡复发的比较:一项关于兰索拉唑、克拉霉素和/或阿莫西林不同给药方案的随机、双盲、多中心研究。
Am J Gastroenterol. 1998 Apr;93(4):584-90. doi: 10.1111/j.1572-0241.1998.169_b.x.
3
Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.质子泵抑制剂联合治疗幽门螺杆菌感染的胃溃疡患者。
J Clin Gastroenterol. 1995;20 Suppl 2:S132-5. doi: 10.1097/00004836-199506002-00036.
4
Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.兰索拉唑根除幽门螺杆菌的临床疗效。
J Clin Gastroenterol. 1995;20 Suppl 2:S112-4. doi: 10.1097/00004836-199506002-00030.
5
Eradication of Helicobacter pylori with lansoprazole, amoxicillin, and plaunotol in duodenal ulcer patients.十二指肠溃疡患者使用兰索拉唑、阿莫西林和普拉诺 Tol 根除幽门螺杆菌
J Clin Gastroenterol. 1995;20 Suppl 2:S128-31. doi: 10.1097/00004836-199506002-00035.
6
Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing.
J Clin Gastroenterol. 1995;20 Suppl 2:S118-20. doi: 10.1097/00004836-199506002-00032.
7
Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori.兰索拉唑联合或不联合阿莫西林对溃疡愈合的影响:与幽门螺杆菌根除的关系。
J Clin Gastroenterol. 1995;20 Suppl 2:S107-11. doi: 10.1097/00004836-199506002-00029.
8
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.一项关于兰索拉唑、阿莫西林和克拉霉素三联疗法根除日本消化性溃疡患者幽门螺杆菌的多中心、双盲研究。
Helicobacter. 2001 Sep;6(3):254-61. doi: 10.1046/j.1523-5378.2001.00037.x.
9
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.兰索拉唑与阿莫西林联合疗法治疗幽门螺杆菌感染的双盲、多中心评估
Helicobacter. 1996 Dec;1(4):243-50. doi: 10.1111/j.1523-5378.1996.tb00046.x.
10
Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?胃溃疡的深度会影响阿莫西林和兰索拉唑联合的改良疗法对幽门螺杆菌相关性胃溃疡的治疗效果吗?
Can J Gastroenterol. 2000 Oct;14(9):761-6. doi: 10.1155/2000/340942.

引用本文的文献

1
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.幽门螺杆菌阳性人群消化性溃疡疾病的根除治疗。
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD003840. doi: 10.1002/14651858.CD003840.pub5.
2
Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.兰索拉唑。其治疗酸相关性疾病的药理特性及临床疗效的最新进展。
Drugs. 1997 Sep;54(3):473-500. doi: 10.2165/00003495-199754030-00010.